| scholarly article | Q13442814 |
| P2093 | author name string | Brian D Juran | |
| Konstantinos N Lazaridis | |||
| Douglas L Nguyen | |||
| P2860 | cites work | Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants | Q24633806 |
| Apotopes and the biliary specificity of primary biliary cirrhosis | Q24646460 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis | Q28298973 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis. | Q32064450 | ||
| WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C. | Q33291074 | ||
| Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
| Chronic cholestatic diseases | Q33870255 | ||
| Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis | Q33916636 | ||
| Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | Q34330984 | ||
| Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients | Q34462959 | ||
| The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales | Q34476962 | ||
| Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality | Q34496270 | ||
| The immunology of primary biliary cirrhosis: the end of the beginning? | Q34775513 | ||
| Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years | Q34932835 | ||
| Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies | Q35214512 | ||
| The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis | Q35417595 | ||
| Genetic factors in the pathogenesis of primary biliary cirrhosis | Q35573908 | ||
| Primary biliary cirrhosis: report of a focus study group | Q35894578 | ||
| Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis | Q35968030 | ||
| Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation | Q36082965 | ||
| The enigma of primary biliary cirrhosis | Q36119459 | ||
| Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy | Q36798266 | ||
| Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene | Q37036965 | ||
| The causes of primary biliary cirrhosis: Convenient and inconvenient truths | Q37039889 | ||
| Genetics and genomics of primary biliary cirrhosis | Q37154318 | ||
| Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment | Q37154329 | ||
| Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? | Q37228810 | ||
| Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity | Q37372660 | ||
| The geographical distribution of primary biliary cirrhosis in a well-defined cohort. | Q39587052 | ||
| Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis | Q40186249 | ||
| Epidemiology and natural history of primary biliary cirrhosis in a US community | Q40735092 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| Transplantation trends in primary biliary cirrhosis. | Q42632785 | ||
| Risk factors for primary biliary cirrhosis in a cohort of patients from the united states | Q44933098 | ||
| Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations | Q45010914 | ||
| The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis | Q45247238 | ||
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid | Q46126105 | ||
| Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis | Q46408092 | ||
| Modafinil for the treatment of fatigue in primary biliary cirrhosis | Q46735291 | ||
| Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment | Q46795010 | ||
| Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence | Q48496394 | ||
| Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis | Q48758554 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. | Q50628941 | ||
| Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. | Q53527400 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Primary biliary cirrhosis | Q56854243 | ||
| CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis | Q56906087 | ||
| Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region | Q57614675 | ||
| Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study | Q70549920 | ||
| Primary biliary cirrhosis with pruritus in India | Q73566881 | ||
| An exploratory population-based case-control study of primary biliary cirrhosis | Q73746110 | ||
| Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis | Q73979498 | ||
| Bioavailability of four ursodeoxycholic acid preparations | Q74260266 | ||
| Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis | Q74529900 | ||
| Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial | Q77872001 | ||
| Prevalence of autoimmune liver disease in Alaska Natives | Q78309924 | ||
| Liver transplantation for primary biliary cirrhosis | Q79240270 | ||
| Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis | Q80073128 | ||
| HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study | Q80188338 | ||
| Primary biliary cirrhosis | Q81246142 | ||
| The pruritus of cholestasis | Q81410186 | ||
| Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites | Q82639990 | ||
| Primary biliary cirrhosis | Q84230884 | ||
| P433 | issue | 5 | |
| P921 | main subject | primary biliary cholangitis | Q1072420 |
| P304 | page(s) | 647-654 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Best Practice and Research: Clinical Gastroenterology | Q15754316 |
| P1476 | title | Primary biliary cirrhosis | |
| P478 | volume | 24 |
| Q34643140 | Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk |
| Q41361892 | Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis |
| Q55332862 | External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid. |
| Q38210250 | Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. |
| Q85282691 | Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers |
| Q85076607 | Integrative role of MRI in the evaluation of primary biliary cirrhosis |
| Q47567609 | Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. |
| Q37951386 | Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review |
| Q26853649 | Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy |
| Q28397178 | The Burnout Conundrum: Nature Versus Nurture? |
| Q35187219 | The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis |
Search more.